NATERA, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
NATERA, INC. (NTRA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $34.50 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Notes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2017-03-16
- NATERA, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2016 was $34.50M, a 40.82% increase from fiscal 2015.
- NATERA, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2015 was $24.50M, a 2622.22% increase from fiscal 2014.
- NATERA, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2014 was $900.00K, a 91.67% decline from fiscal 2013.
- NATERA, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2013 was $10.80M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2016-12-31 | $34.50M 10-K · filed 2017-03-16 |
| 2015-12-31 | $24.50M 10-K · filed 2017-03-16 |
| 2014-12-31 | $900.00K 10-K · filed 2017-03-16 |
| 2013-12-31 | $10.80M 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |